Myrtle Beach, SC Inpatient Addiction Rehabs - Find a Program Today

Myrtle Beach draws 20 million tourists annually to its beaches and boardwalks, yet behind the vacation facade, residents face addiction treatment challenges common to resort economies. While 50 facilities operate within a 25-mile radius of the city, zero offer on-site medical detox—a critical gap that forces residents requiring medically supervised withdrawal to travel 90+ miles to Charleston or Columbia. This creates a dangerous barrier in a community where 15.3% of the population lives below the poverty line and seasonal employment patterns leave many without consistent health coverage. For Myrtle Beach's 36,064 residents, accessing addiction treatment means navigating a landscape where local outpatient care exists but the most acute medical needs require leaving Horry County entirely.

Navigating Myrtle Beach's Treatment Landscape Without Local Detox

Myrtle Beach and surrounding Horry County have 50 treatment facilities within a 25-mile radius, but zero provide medical detox services—meaning anyone experiencing severe alcohol or benzodiazepine withdrawal, or requiring supervised opioid withdrawal management, must coordinate transfer to Charleston or Columbia before accessing local residential programs. The 12 medication-assisted treatment programs operating locally serve as the primary resource for opioid use disorder, offering buprenorphine or naltrexone without requiring inpatient detox.

This detox gap fundamentally shapes treatment pathways. Outpatient MAT programs can initiate buprenorphine for people with opioid use disorder who aren't in acute withdrawal, while residential programs accept clients who've completed detox elsewhere. SC DAODAS licensing requirements ensure facilities meet state quality standards, but geography determines access—residents without transportation to Charleston face a structural barrier before treatment even begins.

Addiction Challenges in a Tourism-Dependent Economy

Myrtle Beach's 36,064 residents navigate addiction treatment in an economy where 15.3% live below the poverty line and median household income reaches $50,558—figures that mask the instability of seasonal tourism employment (Source: U.S. Census Bureau, 2022). Restaurant workers, hotel staff, and entertainment employees often lose hours or jobs entirely during winter months, creating insurance coverage gaps precisely when financial stress intensifies substance use.

The seasonal employment cycle creates a treatment access paradox. Workers may have employer-sponsored insurance from March through August, then lose coverage in September when tourist traffic drops. This forces decisions about whether to start treatment during employed months—risking job loss due to treatment time—or wait until off-season when coverage disappears. The transient nature of resort communities further complicates recovery, as peer support networks shift with seasonal population changes.

While county-level overdose data isn't publicly available for Horry County, South Carolina mirrors national trends where fentanyl now contaminates heroin, counterfeit pills, and increasingly cocaine supplies. The 12 local MAT programs address this crisis by providing medications that block opioid effects and reduce overdose risk, though the absence of detox facilities means people in acute crisis must stabilize elsewhere first.

50 Treatment Facilities Serving Horry County: What's Actually Available

The 50 facilities within 25 miles of Myrtle Beach include 12 programs offering medication-assisted treatment for opioid use disorder, plus residential and outpatient programs that require clients to complete medical detox before admission (Source: SC DAODAS licensed facilities). This creates a two-tier system where MAT programs can serve as first-contact points for opioid addiction, while residential treatment requires prior coordination with Charleston or Columbia detox centers.

SC DAODAS licensing ensures facilities meet clinical staffing requirements, maintain proper medication protocols, and provide evidence-based care. The 25-mile radius extends into Conway and other Horry County communities, expanding options beyond Myrtle Beach city limits. Outpatient programs offer flexibility for employed residents, though evening appointment availability varies by facility. Residential programs typically require 30-90 day commitments, creating employment conflicts for seasonal workers whose job security depends on constant availability during peak months.

The 12 MAT programs represent the most accessible local option, particularly for working residents. Buprenorphine can be prescribed in office-based settings with monthly follow-ups, while naltrexone injections require visits every 28 days. Both allow continued employment while addressing opioid use disorder.

Paying for Treatment in South Carolina Without Medicaid Expansion

South Carolina has not expanded Medicaid, creating a coverage gap for Myrtle Beach residents earning between 100-138% of federal poverty level—approximately $15,060 to $20,783 for individuals (Source: CMS, 2024). With median household income at $50,558 and 15.3% living below poverty, many families earn too much for traditional Medicaid but too little to afford marketplace plans, even with subsidies.

Mental health parity protections apply to private insurance plans, requiring addiction treatment coverage equivalent to medical benefits. However, seasonal workers frequently lose employer coverage during off-season months, forcing treatment interruptions or out-of-pocket payment. SC DAODAS operates a state-funded system that may cover limited treatment slots for uninsured residents, though availability varies and often involves waiting lists.

The detox gap compounds financial barriers—traveling to Charleston for 5-7 day medical detox, then returning to Myrtle Beach for residential treatment, requires transportation costs and potential lost wages that families earning near the poverty line cannot absorb. MAT programs offer a lower-cost pathway since outpatient visits cost less than residential care, though medication costs vary significantly between generic buprenorphine and brand-name formulations.